Media coverage
1
Media coverage
Title PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV) Media name/outlet South Africa - Knowledia News Country/Territory South Africa Date 3/05/23 URL ct.moreover.com/?a=50679056365&p=1gw&v=1&x=_Bg4LJ03CJBzIhYvaJDGmA Persons John Mascarenhas